Arginine Dependency Is a Therapeutically Exploitable Vulnerability in Chronic Myeloid Leukemic Stem Cells

Researchers performed an amino acid drop-out screen and applied pre-clinical models of chronic phase chronic myeloid leukemia (CML) to identify arginine as a nutrient essential for primary human CML cells.